Comparison of Outcomes after Transplantation of G-CSF-Stimulated Bone Marrow Grafts versus Bone Marrow or Peripheral Blood Grafts from HLA-Matched Sibling Donors for Patients with Severe Aplastic Anemia

被引:45
作者
Chu, Roland [2 ]
Brazauskas, Ruta
Kan, Fangyu [3 ]
Bashey, Asad [4 ]
Bredeson, Christopher
Camitta, Bruce
Chiang, Kuang-Yueh [5 ]
Frangoul, Haydar [6 ]
Gale, Robert Peter [7 ]
Gee, Adrian [8 ]
George, Biju [9 ]
Goldman, Frederick D. [10 ]
Gross, Thomas G. [11 ]
Gupta, Vikas [12 ]
Hale, Gregory A. [13 ]
Isola, Luis [14 ]
Urbana Ispizua, Alvaro [15 ]
Lazarus, Hillard [16 ]
Marsh, Judith [17 ]
Russell, James [18 ]
Sabloff, Mitchell [19 ]
Waller, Edmund K. [5 ]
Eapen, Mary [1 ]
机构
[1] Med Coll Wisconsin, Ctr Int Blood & Marrow Transplant Res, Ctr Stat, Milwaukee, WI 53226 USA
[2] Childrens Hosp Michigan, Detroit, MI 48201 USA
[3] Natl Marrow Donor Program, Minneapolis, MN USA
[4] Blood & Marrow Transplant Grp Georgia, Atlanta, GA USA
[5] Emory Univ, Atlanta, GA 30322 USA
[6] Vanderbilt Univ, Nashville, TN USA
[7] Celgene Corp, Summit, NJ USA
[8] Baylor Coll Med, Houston, TX 77030 USA
[9] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India
[10] Childrens Hosp Alabama, Birmingham, AL USA
[11] Nationwide Childrens Hosp, Columbus, OH USA
[12] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[13] Univ S Florida, All Childrens Hosp, St Petersburg, FL 33701 USA
[14] Mt Sinai Med Ctr, New York, NY 10029 USA
[15] Hosp Univ Virgen del Rocio, Seville, Spain
[16] Case Western Reserve Univ, Cleveland, OH 44106 USA
[17] Kings Coll Hosp London, London, England
[18] Univ Calgary, Calgary, AB, Canada
[19] Univ Ottawa, Ottawa, ON, Canada
关键词
G-mobilized BM; GVHD; Aplastic anemia; Survival; VERSUS-HOST-DISEASE; TERM-FOLLOW-UP; STEM-CELLS; PROGENITOR CELLS; HIGH-RISK; RECIPIENTS;
D O I
10.1016/j.bbmt.2010.10.029
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We compared outcomes of patients with severe aplastic anemia (SAA) who received granulocyte-colony stimulating factor (G-CSF)-stimulated bone marrow (G-BM) (n=78), unstimulated bone marrow (BM) (n=547), or peripheral blood progenitor cells (PBPC) (n=134) from an HLA-matched sibling. Transplantations occurred in 1997 to 2003. Rates of neutrophil and platelet recovery were not different among the 3 treatment groups. Grade 2-4 acute graft-versus-host disease (aGVHD) (relative risk [RR]=0.82, P=.539), grade 3-4 aGVHD (RR=0.74, P=.535), and chronic GVHD (cGVHD) (RR=1.56, P=.229) were similar after G-BM and BM transplants. Grade 2-4 aGVHD (RR=2.37, P=.012) but not grade 3-4 aGVHD (RR=1.66, P=.323) and cGVHD (RR=5.09, P<.001) were higher after PBPC transplants compared to G-BM. Grade 2-4 (RR=2.90, P<.001), grade 3-4 (RR=2.24, P=.009) aGVHD and cGVHD (RR=3.26, P<.001) were higher after PBPC transplants compared to BM. Mortality risks were lower after transplantation of BM compared to G-BM (RR=0.63, P=.05). These data suggest no advantage to using G-BM and the observed higher rates of aGVHD and cGVHD in PBPC recipients warrants cautious use of this graft source for SAA. Taken together, BM is the preferred graft for HLA-matched sibling transplants for SAA. Biol Blood Marrow Transplant 17: 1018-1024 (2011) (C) 2011 American Society for Blood and Marrow Transplantation
引用
收藏
页码:1018 / 1024
页数:7
相关论文
共 20 条
[1]  
ATKINSON K, 1990, BLOOD, V75, P2459
[2]   Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. [J].
Bensinger, WI ;
Martin, PJ ;
Storer, B ;
Clift, R ;
Forman, SJ ;
Negrin, R ;
Kashyap, A ;
Flowers, MED ;
Lilleby, K ;
Chauncey, TR ;
Storb, R ;
Appelbaum, FR ;
Rowley, S ;
Heimfeld, S ;
Blume, K .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (03) :175-181
[3]   Long-term follow-up of high-risk allogeneic peripheral-blood stem-cell transplant recipients: Graft-versus-host disease and transplant-related mortality [J].
Brown, RA ;
Adkins, D ;
Khoury, H ;
Vij, R ;
Goodnough, LT ;
Shenoy, S ;
DiPersio, JF .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (03) :806-812
[4]  
CAMITTA BM, 1979, BLOOD, V53, P504
[5]  
Champlin RE, 2000, BLOOD, V95, P3702
[6]   Assessment of G-CSF stimulated BM hematopoietic stem cells in normal donors [J].
Chiang, KY ;
Lamb, L ;
Clark, J ;
Worthington-White, D ;
Rich, I ;
Henslee-Downey, PJ .
CYTOTHERAPY, 2002, 4 (01) :55-63
[7]   Bone marrow mobilized with granulocyte colony-stimulating factor in related allogeneic transplant recipients: A study of 29 patients [J].
Couban, S ;
Messner, HA ;
Andreou, P ;
Egan, B ;
Price, S ;
Tinker, L ;
Meharchand, J ;
Forrest, DL ;
Lipton, J .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2000, 6 (4A) :422-427
[8]   Autologous bone marrow transplantation in non-Hodgkin's lymphoma patients: effect of a brief course of G-CSF on harvest and recovery [J].
Damiani, D ;
Grimaz, S ;
Infanti, L ;
Sperotto, A ;
Silvestri, F ;
Geromin, A ;
Cerno, M ;
Savignano, C ;
Michieli, M ;
Skert, C ;
Fanin, R ;
Baccarani, M .
BONE MARROW TRANSPLANTATION, 1999, 24 (07) :757-761
[9]   Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents:: The histocompatibility and alternate stem cell source working committee of the International Bone Marrow Transplant Registry [J].
Eapen, M ;
Horowitz, MM ;
Klein, JP ;
Champlin, RE ;
Loberiza, FR ;
Ringdén, O ;
Wagner, JE .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (24) :4872-4880
[10]   Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival [J].
Eapen, Mary ;
Logan, Brent R. ;
Confer, Dennis L. ;
Haagenson, Michael ;
Wagner, John E. ;
Weisdorf, Daniel J. ;
Wingard, John R. ;
Rowley, Scott D. ;
Stroncek, David ;
Gee, Adrian P. ;
Horowitz, Mary M. ;
Anasetti, Claudio .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (12) :1461-1468